Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: “What is scientific and sexy is driven by what can be monetized.” Michael Retsky awoke from surgery to bad news. via Pocket
No comments:
Post a Comment